Corpus Intelligence IC Memo — MARINERS HOSPITAL 2026-04-26 21:27 UTC
IC Memo — MARINERS HOSPITAL
Investment Committee Memorandum | FL | 16 beds | Grade C | EBITDA uplift $5.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MARINERS HOSPITAL

CCN 101313 | MONROE, FL | 16 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MARINERS HOSPITAL is a 16-bed suburban community hospital in MONROE, FL with $74.3M in net patient revenue and a 17.0% operating margin. The hospital serves a payer mix of 41.0% Medicare, 1.9% Medicaid, and 57.2% commercial.

Thesis: Turnaround. Our ML models identify $5.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.0% to 24.4% (+736bps).

Net Revenue HCRIS$74.3M
Current EBITDA COMPUTED$12.7M
Operating Margin COMPUTED17.0%
Occupancy HCRIS29.6%
Revenue / Bed COMPUTED$4.6M
Net-to-Gross HCRIS33.0%
Distress Probability ML47.9%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
17
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 17.0% places it above the state median. Among 17 size-comparable peers (8-32 beds), the median margin is -18.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MARINERS HOSPITAL (Target)FL16$74.3M17.0%
HENDRY REGIONAL MEDICAL CENTERFL25$41.1M-20.8%
ED FRASER MEMORIAL HOSPITALFL21$40.7M17.8%
MIAMI JEWISH HEALTH SYSTEMS IFL32$36.6M-50.0%
ADVENTHEALTH WAUCHULAFL25$35.5M10.0%
NORTHWEST FLORIDA COMMUNITY HOFL25$35.2M-2.4%
ST JOHNS REHABILITATION HOSPITFL26$24.8M-18.6%
DOCTORS MEMORIAL HOSPITALFL20$20.5M-3.5%
ASCENSION SACRED HEART GULFFL19$19.5M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.6M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$905K+122bp9mo
Clean Claim Rate88.0%96.0%$48K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.6M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$905K
Clean Claim Rate
$48K
Total EBITDA Uplift$5.5M
Current EBITDA$12.7M
+ RCM Uplift+$5.5M
Pro Forma EBITDA$18.1M
Current Margin17.0%
Pro Forma Margin24.4%
WC Released (1x)$2.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$19.5M$138.2M7.10x48.0%
Base (11x exit)10.0x11.0x$19.5M$158.4M8.13x52.1%
Bull Case9.0x11.0x$17.5M$182.8M10.43x59.8%
Bull (12x exit)9.0x12.0x$17.5M$204.6M11.67x63.5%
Bear Case11.0x10.0x$21.4M$104.5M4.88x37.3%
Bear (11x exit)11.0x11.0x$21.4M$122.0M5.69x41.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 29.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 8-32 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-50.0% / P50=-18.6% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.